Latest SAPIR News & Updates

New Delhi, May 15 (IANS) The US pharmaceutical and biotechnology sector has become critically dependent on Chinese inputs, which makes it vulnerable to supply chain risks from a foreign country, a report has said.An article in The National Interest, a US-based online publication cites the example of Heparin, a blood thinner, on which US patients have to excessively depend on supplies from China.About 70 per cent of the US supply of the drug originates from the heartland of China. The two US-base…